Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat
E. Obuchowicz et J. Turchan, Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat, EUR NEUROPS, 9(1-2), 1999, pp. 51-59
The effects of acute, subchronic (14 days) or chronic (28 days) intraperito
neal (i.p.) administration of chlorpromazine (2 or 10 mg/kg), haloperidol (
0.5 or 2 mg/kg) or sulpiride (50 or 100 mg/kg) on the neuropeptide Y (NPY)
system in the rat nucleus accumbens were studied, NPY-like immunoreactivity
(NPY-LI) decreased in a dose- and time-dependent manner, and was the lowes
t after haloperidol. NPY-LI levels increased 8 days after withdrawal of chr
onic drugs treatment. Acute administration of haloperidol reduced NPY mRNA,
while subchronic treatment did not change it. Subchronic i.p. administrati
on of the dopamine D-1-like antagonist SCH 23390 (1 mg/kg) reduced NPY-LI l
evels but the alpha(1)-adrenergic antagonist prazosin (0.2 mg/kg) had no ef
fect. The effect of sulpiride coadministered with SCH 23390 was greater tha
n that of SCH 23390 alone, while prazosin coadministered with sulpiride ins
ignificantly reduced the effect of sulpiride. The dopamine D-2/D-3 agonist
quinpirole given as a single injection (3 mg/kg) did not alter NPY-LI conte
nt by itself but antagonized the chlorpromazine-induced decrease and attenu
ated the haloperidol-induced decrease. Our findings indicate that the accum
bens NPY system is markedly affected by the antipsychotics studied, and sug
gest that their effects may be in part mediated by blockade of D-2-like (D-
2, D-3) and D-1 dopaminergic receptors. (C) 1999 Elsevier Science B.V./ECNP
. All rights reserved.